CONMED (NYSE:CNMD) (NYSE: CNMD) is a global medical technology company specializing in the development, manufacture and distribution of surgical devices and consumable products. With a focus on minimally invasive procedures, the company’s portfolio spans general surgery, orthopedics and endomechanics, providing solutions that enable surgeons to achieve precision and efficiency in the operating room. CONMED’s product offerings include advanced energy devices for tissue sealing and coagulation, suture passers, endoscopic instruments, arthroscopy shavers, fluid management systems and sterile processing equipment.
Founded in 1970 and headquartered in Largo, Florida, CONMED has grown through both organic innovation and strategic acquisitions. Over its history, the company has integrated complementary businesses to expand its technology platform, notably the acquisition of Linvatec in 2008, which broadened its reach in sports medicine and arthroscopy. This expansion has allowed CONMED to continuously refine its R&D capabilities, bringing new products to market that address evolving surgical needs and enhance patient outcomes.
CONMED serves a diversified customer base that includes hospitals, ambulatory surgery centers and specialty clinics across more than 70 countries. Its global footprint encompasses direct sales operations in North America, Europe and Asia-Pacific, supported by a network of independent distributors in emerging markets. By combining localized sales support with centralized manufacturing and quality assurance processes, the company maintains consistent product performance and regulatory compliance worldwide.
Leadership at CONMED is anchored by Chairman and Chief Executive Officer Keith H. Valentine, who has guided the company since 2003. Under his stewardship, CONMED has focused on driving operational efficiency, investing in new technologies and forging partnerships with clinicians to address unmet surgical needs. The company’s commitment to innovation is reflected in its annual investment programs and collaborative research initiatives, positioning it as a trusted partner for healthcare providers seeking advanced, reliable surgical solutions.
